An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus.
about
A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infectionImmunogenetic mechanisms driving norovirus GII.4 antigenic variationSpecificity, cross-reactivity and function of antibodies elicited by Zika virus infectionStable long-term cultures of self-renewing B cells and their applicationsThe Cloning and Expression of Human Monoclonal Antibodies: Implications for Allergen ImmunotherapyRecent Progress towards Novel EV71 Anti-Therapeutics and VaccinesMonoclonal antibodies: Principles and applications of immmunodiagnosis and immunotherapy for hepatitis C virusThe human IgE repertoireGeneration of Human B-Cell Lines Dependent on CD40-Ligation and Interleukin-4Monitoring the systemic human memory B cell compartment of melanoma patients for anti-tumor IgG antibodiesDifferential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSADevelopment of a Human-Murine Chimeric Immunoglobulin M Antibody for Use in the Serological Detection of Human Flavivirus AntibodiesAntibodies against viruses: passive and active immunizationThe structural basis for serotype-specific neutralization of dengue virus by a human antibodyDelineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralizationReverse vaccinology 2.0: Human immunology instructs vaccine antigen designCross-reacting antibodies enhance dengue virus infection in humansEmerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious DiseasesSevere acute respiratory syndrome coronavirus as an agent of emerging and reemerging infectionDevelopment of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxisCommon variants in CDKN2B-AS1 associated with optic-nerve vulnerability of glaucoma identified by genome-wide association studies in JapaneseAntigen-specific monoclonal antibodies isolated from B cells expressing constitutively active STAT5Generation of human antigen-specific monoclonal IgM antibodies using vaccinated "human immune system" miceProphylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenzaHuman monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutantsMax Bergmann lecture protein epitope mimetics in the age of structural vaccinologyFrom SARS to MERS: evidence and speculation.Generation of human neutralizing monoclonal antibodies against the 2009 pandemic H1N1 virus from peripheral blood memory B lymphocytesHuman monoclonal antibodies targeting the haemagglutinin glycoprotein can neutralize H7N9 influenza virus.Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccineScreening of random peptide library of hemagglutinin from pandemic 2009 A(H1N1) influenza virus reveals unexpected antigenically important regions.A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody.Production of an anti-severe acute respiratory syndrome (SARS) coronavirus human monoclonal antibody Fab fragment by using a combinatorial immunoglobulin gene library derived from patients who recovered from SARS.Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus.Isolation of human monoclonal antibodies by mammalian cell display.Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome.Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathwayHuman antibody neutralizes severe Fever with thrombocytopenia syndrome virus, an emerging hemorrhagic Fever virus.
P2860
Q24794470-72F31E4B-A697-48AD-92DD-C1E57B9D9C17Q24810360-1CFE4AFD-AD2F-4CEC-85CE-EC58087C0ACFQ26252507-53006C2B-C954-4B2E-BCF4-497D8CB4C9F3Q26766723-1D48B96D-6D47-4AD9-ACF7-FAD3C60299EAQ26771289-AFD6A2FC-CDD5-4D1C-829D-A9F31B5890EBQ26775734-401DB491-EBD7-4F72-9C2B-C904BC29C9E3Q26783378-4510304A-69C9-4D28-9C94-09A079324C19Q26865573-DC563DF4-7E3C-4AEA-9D31-ADBF46F1560AQ27005880-C30CE563-C3B0-4AC0-A5CC-19F5B258BAF1Q27345217-084961C8-882D-4DAA-9F01-42BE921B3D8BQ27349502-B84E8522-698C-43CB-A604-C2758FB6EC45Q27488387-1387C55A-9BBC-474D-A2A4-2D384E5EFAECQ27489392-8D0ADDD4-E38A-40B5-9B70-67073817F0E8Q27681306-7B87949F-572B-4D50-8D2F-0F4EC099B5CCQ27684578-5A301E01-2927-4DE7-B99E-62FEC8130EEFQ28075274-957A2B4E-910E-4A57-B756-5B0E59914545Q28281588-37174452-D1B2-4ACD-AD51-7482A973C23DQ28383084-6247D7A1-47DE-44ED-A5AC-799C956D5AF4Q28383088-A89060C9-ABF6-45C0-A0E4-4838E74537BAQ28601417-6926E311-565B-4D28-9911-44573FA4CCD8Q28731370-11FDBD67-5F21-4932-941E-EAFE8D6A56FBQ28740998-3183671E-4BAE-485D-80D7-5B731AC966D6Q28749033-779F43EF-317B-4E90-9FD7-75C71B0A766DQ28757651-D194EAF5-193C-44F2-8519-7C78F6B19822Q28768526-A214DE4C-CE40-496A-9EC8-4924A0EBE9B8Q30155145-16BA333B-2BD3-41F8-9D49-B617A6A07BAAQ30244685-95F55154-6BED-4303-8B1B-3EB807006EA0Q30352589-DE5A7F18-AC26-4E35-897C-5B85EEB4AA34Q30373175-461CF4F4-C7E7-4B27-ACAA-43092B3EED6CQ30388038-65ABFF8F-46A7-4940-B2DC-8927D1A0259BQ30401148-22BAE90F-0E0A-4B54-9527-1346B8BCA449Q30411637-5FCA7982-7FE2-4BE7-B44B-77D0BBAB6C39Q33210858-CFBB44A0-177E-483F-A056-4BA6B536606CQ33239031-D2D32F1C-29E7-4138-8381-9CDE86B52620Q33242774-BB0A7473-57A1-4699-AC43-BDA797BB8944Q33260408-3CCC3696-AEBA-4DF9-9FE8-5D3C984CCD48Q33371477-DD047F31-285C-45D7-9EBA-5AEE50E7AED5Q33373065-3AB052F0-6050-4CFF-B881-AB5B8CCA9165Q33383237-E2CE57A3-F2A0-4044-95AD-239375B7BD96Q33409160-4972EAA5-EA34-43ED-8026-F1AB57A35B8A
P2860
An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
An efficient method to make hu ...... alization of SARS coronavirus.
@en
An efficient method to make hu ...... alization of SARS coronavirus.
@nl
type
label
An efficient method to make hu ...... alization of SARS coronavirus.
@en
An efficient method to make hu ...... alization of SARS coronavirus.
@nl
prefLabel
An efficient method to make hu ...... alization of SARS coronavirus.
@en
An efficient method to make hu ...... alization of SARS coronavirus.
@nl
P2093
P50
P921
P356
P1433
P1476
An efficient method to make hu ...... alization of SARS coronavirus.
@en
P2093
Brian R Murphy
Elisabetta Traggiai
Larissa Kolesnikova
Stephan Becker
Yasushi Uematsu
P2888
P304
P356
10.1038/NM1080
P407
P577
2004-07-11T00:00:00Z